eClinical Solutions Delivers elluminate COVID-19 Clinical Trial Analytics
elluminate COVID-19 Analytics support FDA guidance, proactive monitoring and impact analysis of COVID-19 on clinical trial participants for ongoing studiesReleased: April 6, 2020
eClinical Solutions LLC, a leading global provider of cloud-based enterprise software and software-driven clinical data services, today announced an addition to its elluminate® platform, COVID-19 Analytics. These analytics help sponsors proactively manage the risks of COVID-19 for their ongoing clinical trials. The visualizations provide real-time trial information based on numerous data sources, allowing trial managers to focus on those participants and sites most likely experiencing COVID-19 related symptoms and impact.
With the FDA’s recently released guidance on the conduct of clinical trials for medical products during the COVID-19 pandemic, upholding the safety of trial participants, maintaining compliance and minimizing risks to trial integrity are pressing issues for sponsors to manage in their ongoing studies. elluminate COVID-19 Analytics help clinical teams comply with FDA recommendations by enabling sponsors to identify missed visits and forecast upcoming future visits, including those for dosing, which have a greater likelihood to be missed based on a variety of data sources. This allows clinical teams to identify the sites and patients that may need additional resources and support, such as remote visits and additional supplies, to help sustain ongoing participation in the study.
“We developed elluminate COVID-19 Analytics based on feedback from clients looking to expand their use of elluminate for immediate insights on the pandemic’s impact with their ongoing clinical trials,” said Raj Indupuri, CEO of eClinical Solutions. “After hearing similar needs across clients, we rapidly developed a validated, rich analytics app with smart visualizations that can be used for any trial. We are inspired by how hard the research community is working both to find a treatment for COVID-19 and to ensure critical new therapies in development continue to progress. We believe these analytics help minimize risks with trial conduct and help sponsors make better decisions during this time.”
elluminate COVID-19 Analytics are now available and complimentary for all existing elluminate clients. New clients can use them for a reduced rate. For more information on elluminate COVID-19 Analytics, eClinical Solutions is hosting a live webcast on Wednesday, April 8 at 11 am EDT/8 am PDT.
Visit eclinicalsol.com/webinars/elluminate-covid-19-analytics to register.
About eClinical Solutions LLC
eClinical Solutions is a leading global provider of cloud-based enterprise software and software-driven clinical data services. The elluminate® platform provides life sciences companies with greater control of their clinical trial data. elluminate software and data-driven services have been used by more than 100 life sciences companies on more than 500 trials. For more information, visit eclinicalsol.com.